Biodel Plummets As FDA Requests Late-Stage Trials On Linjeta (Strawberry NEWS) - Wall Street Journal Biodel Plummets As FDA Requests Late-Stage Trials On Linjeta (Strawberry NEWS) - Wall Street Journal

Monday, November 1, 2010

Biodel Plummets As FDA Requests Late-Stage Trials On Linjeta (Strawberry NEWS) - Wall Street Journal

Biodel Plummets As FDA Requests Late-Stage Trials On Linjeta - Wall Street Journal

Biodel Plummets As FDA Requests Late-Stage Trials On Linjeta
Wall Street Journal
NEW YORK (Dow Jones)--Shares of Biodel Inc. (BIOD) lost more than half their value in premarket trading Monday after the government ...
Biodel shares plunge after FDA demands two new Ph3 trialsFierceBiotech

all 26 news articles »

Source: news.google.com

Asian Shares End Mostly Higher; China, HK Rise On Strong Data - Wall Street Journal

Straits Times

Asian Shares End Mostly Higher; China, HK Rise On Strong Data
Wall Street Journal
Shares in Hong Kong and China advanced, led by commodities and financial sectors, after the release of the October purchasing managers' index. ...
HK Shares End Higher Led By Commodities, Financial FirmsWall Street Journal
Asia shares mixed ahead of US Fed meetingAFP
Hong Kong shares jump after China data; banks riseMarketWatch

all 157 news articles »

Source: news.google.com

Energy stocks jump on Baker Hughes, crude - MarketWatch

Energy stocks jump on Baker Hughes, crude
MarketWatch
NEW YORK (MarketWatch) — Higher oil prices and strength in shares of Baker Hughes contributed to early gains in energy-sector ...

and more »

Source: news.google.com

No comments: